title: [Molecular-biological subtypes of breast cancer in the Republic of Uzbekistan].
abstract: An interest to the heterogeneity of breast cancer (BC) is not being quenched. At the present stage of clinical oncology treatment of breast cancer is based not only on the "classic" data as stage of disease, grade, histology but molecular-biological characteristics studied in different populations. In the Republic of Uzbekistan these characteristics of breast cancer are published in fragments, which was the purpose of carrying out a large-scale study to obtain reliable comprehensive data on the issue.
authors.forename: G A
authors.initials: GA
authors.lastname: Khakimov
authors.forename: N R
authors.initials: NR
authors.lastname: Shayusupov
authors.forename: G F
authors.initials: GF
authors.lastname: Miryusupova
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000453:epidemiology / Q000473:pathology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D064726:Triple Negative Breast Neoplasms / Q000737:chemistry / Q000473:pathology; D014610:Uzbekistan / Q000453:epidemiology
chemical_list: D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human